Universal mRNA Influenza Vaccine Elicits Broad Neutralizing Antibodies Against All Known Subtypes in Phase II
A universal mRNA influenza vaccine targeting the conserved hemagglutinin stalk has elicited broad neutralizing antibodie...
Read More →A universal mRNA influenza vaccine targeting the conserved hemagglutinin stalk has elicited broad neutralizing antibodie...
Read More →Researchers have successfully transplanted a 3D-bioprinted, vascularized kidney construct into a primate, where it funct...
Read More →A novel engineered psychobiotic therapy targeting the gut-brain axis has achieved an 80% remission rate in patients with...
Read More →An AI-designed senolytic peptide, SEN-77, has successfully cleared senescent cells and reversed epigenetic aging biomark...
Read More →A Phase III trial demonstrates that a personalized mRNA neoantigen vaccine combined with chemotherapy and immunotherapy ...
Read More →A Phase II clinical trial demonstrates that a novel in-vivo CRISPR-Cas12a gene editing therapy safely halts the progress...
Read More →AI data centers now consume 12% of the US electricity grid, prompting the DOE to declare an emergency and mandate the ac...
Read More →Meta and Microsoft have open-sourced Llama-4-Edge, a 400B parameter multimodal AI model that runs locally on smartphones...
Read More →SpaceX has successfully completed the first fully autonomous orbital refueling of a Starship vehicle, a critical milesto...
Read More →IBM and Google have achieved Quantum Advantage in protein folding using a 10,000-qubit processor and AI, accelerating th...
Read More →Neuralink has achieved commercial rollout of its high-bandwidth BCI implant, restoring full motor function and digital c...
Read More →The EU has levied €4.2 billion in fines against major tech giants for violating the AI Act's deepfake labeling and tra...
Read More →